Effect of dutasteride on tumor proliferation during the regrowth phase of intermittent androgen ablation therapy in men with advanced prostate cancer.

Authors

null

Daniel H. Shevrin

NorthShore University HealthSystem, Evanston, IL

Daniel H. Shevrin , Gary R. MacVicar , Timothy Kuzel , Walter Michael Stadler , Borko Jovanovic , Karen Kaul , Zhou Wang

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2013 Genitourinary Cancers Symposium

Session Type

Poster Session

Session Title

General Poster Session A: Prostate Cancer

Track

Prostate Cancer

Sub Track

Prostate Cancer

Clinical Trial Registration Number

NCT00668642

Citation

J Clin Oncol 31, 2013 (suppl 6; abstr 21)

DOI

10.1200/jco.2013.31.6_suppl.21

Abstract #

21

Poster Bd #

B12

Abstract Disclosures

Similar Posters

First Author: Yifu Shi

Poster

2024 ASCO Genitourinary Cancers Symposium

Predicting abiraterone efficacy in advanced prostate cancer: Insights from marker of proliferation Ki-67.

Predicting abiraterone efficacy in advanced prostate cancer: Insights from marker of proliferation Ki-67.

First Author: Fengnian Zhao

First Author: Jian Guan

First Author: Mohamed E. Ahmed